CellaVision AB (OSTO:CEVI) Cash-to-Debt : 5.57 (As of Dec. 2024)

View and export this data going back to 2007. Start your Free Trial

What is CellaVision AB Cash-to-Debt?

Cash to Debt Ratio measures the financial strength of a company. It is calculated as a company's cash, cash equivalents, and marketable securities divide by its debt. CellaVision AB's cash to debt ratio for the quarter that ended in Dec. 2024 was 5.57.

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. Here we can see, CellaVision AB could pay off its debt using the cash in hand for the quarter that ended in Dec. 2024.

The historical rank and industry rank for CellaVision AB's Cash-to-Debt or its related term are showing as below:

OSTO:CEVI' s Cash-to-Debt Range Over the Past 10 Years
Min: 0.59 Med: 3.72 Max: No Debt
Current: 5.57

During the past 13 years, CellaVision AB's highest Cash to Debt Ratio was No Debt. The lowest was 0.59. And the median was 3.72.

OSTO:CEVI's Cash-to-Debt is ranked better than
65.7% of 860 companies
in the Medical Devices & Instruments industry
Industry Median: 1.785 vs OSTO:CEVI: 5.57

CellaVision AB Cash-to-Debt Historical Data

The historical data trend for CellaVision AB's Cash-to-Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: An indication of "No Debt" does not necessarily mean that the company has no debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

* Premium members only.

CellaVision AB Cash-to-Debt Chart

CellaVision AB Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Cash-to-Debt

Get a 7-Day Free Trial

0.77

0.95

1.05

1.88

5.57

CellaVision AB Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Cash-to-Debt	Get a 7-Day Free Trial															1.88	2.98	2.72	3.89	5.57

Competitive Comparison of CellaVision AB's Cash-to-Debt

For the Medical Devices subindustry, CellaVision AB's Cash-to-Debt, along with its competitors' market caps and Cash-to-Debt data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

CellaVision AB's Cash-to-Debt Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, CellaVision AB's Cash-to-Debt distribution charts can be found below:

* The bar in red indicates where CellaVision AB's Cash-to-Debt falls into.

Save Embed

;

Save Embed

;

CellaVision AB Cash-to-Debt Calculation

This is the ratio of a company's Cash, Cash Equivalents, Marketable Securities to its debt. The debt includes the Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation. This ratio measures the financial strength of a company. This ratio is updated quarterly.

CellaVision AB's Cash to Debt Ratio for the fiscal year that ended in Dec. 2024 is calculated as:

Cash to Debt Ratio	=	Cash, Cash Equivalents, Marketable Securities	/	Total Debt
	=	Cash, Cash Equivalents, Marketable Securities	/	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)
	=	149.43	/	(14.171	+	12.678)
	=	5.57

CellaVision AB's Cash to Debt Ratio for the quarter that ended in Dec. 2024 is calculated as:

Cash to Debt Ratio	=	Cash, Cash Equivalents, Marketable Securities	/	Total Debt
	=	Cash, Cash Equivalents, Marketable Securities	/	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)
	=	149.43	/	(14.171	+	12.678)
	=	5.57

CellaVision AB (OSTO:CEVI) Cash-to-Debt Explanation

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. If it is smaller than 1, it means the company has more debt than the cash in hands. In this case, it is important to look the the company's Interest Coverage. Ben Graham requires that a company must have an Interest Coverage of at least 5.

CellaVision AB Cash-to-Debt Related Terms

Thank you for viewing the detailed overview of CellaVision AB's Cash-to-Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

CellaVision AB Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » CellaVision AB (OSTO:CEVI) » Definitions » Cash-to-Debt

Comparable Companies

Traded in Other Exchanges

CLVSF:USA 0MR5:UK C26:Germany

Address

Mobilvagen 12, Lund, SWE, 22362

Website

https://www.cellavision.com

CellaVision AB is engaged in the business of supplying digital solutions for blood and body fluid analysis. Its solutions are based on digital image analysis technology, artificial intelligence, and information technology. The firm's product portfolio consists of CellaVision peripheral blood application, CellaVision advanced RBC application, and CellaVision remote review software. Its customers include mainly large hospital laboratories and commercial laboratories in North America, Europe and China, and Japan. The company derives the majority of its revenue from the sale of analyzers/software.

CellaVision AB Headlines

No Headlines